MEMANTINE HYDROCHLORIDE

MEMANTINE HYDROCHLORIDE was reported 2808 times

These side effects are most commonly reported by patients taking MEMANTINE HYDROCHLORIDE:

# Side effect Count
0 FALL 1030
1 DEATH 958
2 DRUG INEFFECTIVE 883
3 OFF LABEL USE 809
4 CONFUSIONAL STATE 763
5 FATIGUE 665
6 HALLUCINATION 653
7 CONDITION AGGRAVATED 554
8 ASTHENIA 501
9 DIZZINESS 489
10 SOMNOLENCE 469
11 URINARY TRACT INFECTION 454
12 NAUSEA 427
13 DIARRHOEA 410
14 PRODUCT DOSE OMISSION ISSUE 372
15 AGITATION 369
16 GAIT DISTURBANCE 362
17 PNEUMONIA 353
18 DEMENTIA 349
19 HEADACHE 336
20 DECREASED APPETITE 333
21 VOMITING 333
22 DRUG INTERACTION 324
23 DYSPNOEA 302
24 TREMOR 298
25 BRADYCARDIA 287
26 HYPOTENSION 272
27 INSOMNIA 272
28 WEIGHT DECREASED 271
29 CONSTIPATION 270
30 PRODUCT USE IN UNAPPROVED INDICATION 257
31 MALAISE 252
32 MEMORY IMPAIRMENT 251
33 HYPERTENSION 242
34 DELIRIUM 240
35 DEHYDRATION 239
36 PAIN 238
37 AGGRESSION 233
38 BALANCE DISORDER 226
39 LOSS OF CONSCIOUSNESS 225
40 SEIZURE 224
41 DYSPHAGIA 213
42 RASH 211
43 SYNCOPE 202
44 PYREXIA 201
45 COGNITIVE DISORDER 192
46 ABNORMAL BEHAVIOUR 191
47 ACUTE KIDNEY INJURY 191
48 ANXIETY 188
49 HALLUCINATION, VISUAL 187
50 DEMENTIA ALZHEIMER^S TYPE 183
51 DEPRESSION 181
52 GENERAL PHYSICAL HEALTH DETERIORATION 176
53 WEIGHT INCREASED 174
54 PARKINSON^S DISEASE 171
55 DELUSION 169
56 PERIPHERAL SWELLING 169
57 COUGH 168
58 HYPONATRAEMIA 161
59 TOXICITY TO VARIOUS AGENTS 161
60 CONTUSION 160
61 DYSKINESIA 156
62 MOBILITY DECREASED 154
63 ELECTROCARDIOGRAM QT PROLONGED 153
64 BACK PAIN 147
65 DISORIENTATION 146
66 COVID-19 144
67 SPEECH DISORDER 144
68 MUSCULAR WEAKNESS 143
69 PRURITUS 143
70 PULMONARY EMBOLISM 143
71 ARTHRALGIA 135
72 PNEUMONIA ASPIRATION 135
73 PAIN IN EXTREMITY 134
74 PRODUCT USE ISSUE 134
75 CEREBROVASCULAR ACCIDENT 133
76 SEPSIS 130
77 FEELING ABNORMAL 128
78 ANAEMIA 123
79 OEDEMA PERIPHERAL 121
80 CHEST PAIN 120
81 DEPRESSED LEVEL OF CONSCIOUSNESS 119
82 MENTAL STATUS CHANGES 119
83 LETHARGY 118
84 BLOOD PRESSURE INCREASED 116
85 ORTHOSTATIC HYPOTENSION 115
86 OVERDOSE 114
87 HYPERHIDROSIS 113
88 CELLULITIS 112
89 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 110
90 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 110
91 APHASIA 108
92 DISEASE PROGRESSION 107
93 HYPOPHAGIA 106
94 MYOCLONUS 106
95 ATRIAL FIBRILLATION 105
96 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 104
97 BLOOD PRESSURE DECREASED 102
98 HIP FRACTURE 101
99 HAEMOGLOBIN DECREASED 100
100 CARDIAC FAILURE 99
101 POOR QUALITY SLEEP 97
102 RESTLESSNESS 97
103 HOSPITALISATION 96
104 MUSCLE SPASMS 96
105 ENCEPHALOPATHY 95
106 MEDICATION ERROR 94
107 URINARY INCONTINENCE 94
108 DISTURBANCE IN ATTENTION 93
109 HYPERSOMNIA 92
110 MYOCARDIAL INFARCTION 92
111 INFECTION 91
112 MUSCULOSKELETAL STIFFNESS 90
113 SEDATION 90
114 INCORRECT DOSE ADMINISTERED 88
115 SEROTONIN SYNDROME 86
116 ABDOMINAL PAIN 85
117 ABDOMINAL PAIN UPPER 85
118 PLEURAL EFFUSION 85
119 THROMBOCYTOPENIA 85
120 DRUG INTOLERANCE 84
121 ABDOMINAL DISCOMFORT 83
122 THERAPY NON-RESPONDER 83
123 UNRESPONSIVE TO STIMULI 83
124 CEREBRAL HAEMORRHAGE 82
125 RHABDOMYOLYSIS 81
126 VISUAL IMPAIRMENT 80
127 ACCIDENTAL OVERDOSE 79
128 CATARACT 78
129 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 78
130 AMYLOID RELATED IMAGING ABNORMALITY-OEDEMA/EFFUSION 77
131 COMPLETED SUICIDE 76
132 HERPES ZOSTER 76
133 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 76
134 HEAD INJURY 75
135 NEUROLEPTIC MALIGNANT SYNDROME 75
136 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 74
137 SKIN DISORDER 74
138 RENAL FAILURE 73
139 TREATMENT FAILURE 73
140 BLOOD GLUCOSE INCREASED 72
141 COMA 72
142 GASTROINTESTINAL HAEMORRHAGE 72
143 PSYCHOMOTOR HYPERACTIVITY 72
144 CHILLS 71
145 EPILEPSY 71
146 IMPAIRED QUALITY OF LIFE 71
147 IRRITABILITY 71
148 HYPOAESTHESIA 70
149 URINARY RETENTION 70
150 RENAL IMPAIRMENT 69
151 DYSARTHRIA 68
152 GAIT INABILITY 68
153 ILLNESS 68
154 NASOPHARYNGITIS 68
155 DYSSTASIA 67
156 PSYCHOTIC DISORDER 67
157 ADVERSE DRUG REACTION 66
158 AMNESIA 66
159 DEEP VEIN THROMBOSIS 66
160 UNDERDOSE 66
161 ERYTHEMA 64
162 HALLUCINATION, AUDITORY 64
163 MIGRAINE 64
164 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 63
165 IMPAIRED WORK ABILITY 63
166 SUICIDAL IDEATION 63
167 THERAPY INTERRUPTED 63
168 DYSPEPSIA 62
169 ORAL HERPES 62
170 OXYGEN SATURATION DECREASED 62
171 PRODUCTIVE COUGH 62
172 TACHYCARDIA 62
173 SLEEP DISORDER 61
174 SOPOR 61
175 CARDIAC DISORDER 60
176 CATATONIA 60
177 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 60
178 HYPERLIPIDAEMIA 60
179 HYPERSENSITIVITY 60
180 PURPURA 60
181 BONE DENSITY DECREASED 59
182 GLUCOSE TOLERANCE IMPAIRED 59
183 HEART RATE INCREASED 59
184 HYPOKALAEMIA 59
185 ALTERED STATE OF CONSCIOUSNESS 58
186 DRY MOUTH 58
187 RESPIRATORY FAILURE 58
188 THROMBOSIS 58
189 CARDIAC ARREST 57
190 LIVER FUNCTION TEST ABNORMAL 57
191 MYALGIA 57
192 PLATELET COUNT DECREASED 57
193 BODY TINEA 56
194 INFECTION SUSCEPTIBILITY INCREASED 56
195 MANIA 56
196 DRUG-INDUCED LIVER INJURY 55
197 MUSCLE RIGIDITY 55
198 PARAESTHESIA 55
199 RECTAL HAEMORRHAGE 55
200 ANGER 54
201 INTERNATIONAL NORMALISED RATIO INCREASED 54
202 NIGHTMARE 54
203 ALOPECIA 53
204 DRUG ABUSE 53
205 INFLUENZA 53
206 INHIBITORY DRUG INTERACTION 53
207 VISION BLURRED 53
208 HYPERNATRAEMIA 52
209 PARANOIA 52
210 TRANSIENT ISCHAEMIC ATTACK 52
211 WHITE BLOOD CELL COUNT DECREASED 52
212 DEVICE ISSUE 51
213 NONSPECIFIC REACTION 51
214 RHINORRHOEA 51
215 CONTRAINDICATED PRODUCT ADMINISTERED 50
216 NEUROPATHY PERIPHERAL 50
217 DEPRESSED MOOD 49
218 EXTRAPYRAMIDAL DISORDER 49
219 SINUS BRADYCARDIA 49
220 VERTIGO 49
221 BRONCHITIS 48
222 CHEST DISCOMFORT 48
223 FEMUR FRACTURE 48
224 PARKINSONISM 48
225 SWELLING FACE 48
226 ASPARTATE AMINOTRANSFERASE INCREASED 47
227 ATRIOVENTRICULAR BLOCK FIRST DEGREE 47
228 BLOOD CREATININE INCREASED 47
229 HOSPICE CARE 47
230 INFUSION RELATED REACTION 47
231 PLEUROTHOTONUS 47
232 POLLAKIURIA 47
233 ALANINE AMINOTRANSFERASE INCREASED 46
234 CEREBRAL INFARCTION 46
235 HALLUCINATIONS, MIXED 46
236 HEART RATE DECREASED 46
237 INTENTIONAL PRODUCT MISUSE 46
238 PALLOR 46
239 TREATMENT NONCOMPLIANCE 46
240 WITHDRAWAL SYNDROME 46
241 CHRONIC KIDNEY DISEASE 45
242 HYPOTHERMIA 45
243 MALIGNANT NEOPLASM PROGRESSION 45
244 PRESCRIBED UNDERDOSE 45
245 PRESYNCOPE 45
246 THERAPEUTIC RESPONSE UNEXPECTED 45
247 CARDIAC FAILURE CONGESTIVE 44
248 METASTASES TO CENTRAL NERVOUS SYSTEM 44
249 HYPOGLYCAEMIA 43
250 BLOOD CREATINE PHOSPHOKINASE INCREASED 42
251 DYSURIA 42
252 FLUSHING 42
253 GENERALISED TONIC-CLONIC SEIZURE 42
254 HAEMATURIA 42
255 ABDOMINAL DISTENSION 41
256 MENTAL IMPAIRMENT 41
257 OEDEMA 41
258 PRODUCT DOSE OMISSION 41
259 DYSTONIA 40
260 HYPOTHYROIDISM 40
261 JAUNDICE 40
262 NERVOUSNESS 40
263 NEUTROPENIA 40
264 SALIVARY HYPERSECRETION 40
265 DRUG HYPERSENSITIVITY 39
266 ILL-DEFINED DISORDER 39
267 INCONTINENCE 39
268 SUBDURAL HAEMATOMA 39
269 DEVICE DISLOCATION 38
270 HAEMORRHAGE 38
271 HYPERTENSIVE CRISIS 38
272 INTENTIONAL PRODUCT USE ISSUE 38
273 NO ADVERSE EVENT 38
274 TARDIVE DYSKINESIA 38
275 WHITE BLOOD CELL COUNT INCREASED 38
276 ATAXIA 37
277 CONVULSION 37
278 CRYING 37
279 DEMENTIA WITH LEWY BODIES 37
280 EPISTAXIS 37
281 EYE PAIN 37
282 IMMUNE THROMBOCYTOPENIA 37
283 LUNG NEOPLASM MALIGNANT 37
284 ABASIA 36
285 DECUBITUS ULCER 36
286 EYE IRRITATION 36
287 MENTAL DISORDER 36
288 PALPITATIONS 36
289 THERAPY CESSATION 36
290 UNEVALUABLE EVENT 36
291 URTICARIA 36
292 ASTHMA 35
293 ATRIOVENTRICULAR BLOCK 35
294 INJECTION SITE PAIN 35
295 MOVEMENT DISORDER 35
296 PRODUCT USE COMPLAINT 35
297 ARRHYTHMIA 34
298 BLINDNESS 34
299 BLOOD POTASSIUM DECREASED 34
300 BRADYKINESIA 34
301 DIABETES MELLITUS 34
302 GASTROINTESTINAL DISORDER 34
303 JOINT SWELLING 34
304 PANCYTOPENIA 34
305 SKIN EXFOLIATION 34
306 SWELLING 34
307 THERAPEUTIC PRODUCT EFFECT DECREASED 34
308 ADVERSE EVENT 33
309 BEHAVIOUR DISORDER 33
310 BLOOD PRESSURE FLUCTUATION 33
311 DERMATITIS ATOPIC 33
312 DRY SKIN 33
313 FEEDING DISORDER 33
314 HOT FLUSH 33
315 OCULAR HYPERAEMIA 33
316 SEPTIC SHOCK 33
317 SINUSITIS 33
318 ABNORMAL DREAMS 32
319 DROOLING 32
320 DRUG DOSE OMISSION 32
321 HEMIPARESIS 32
322 HYPOKINESIA 32
323 INTENTIONAL DOSE OMISSION 32
324 NECK PAIN 32
325 NEPHROLITHIASIS 32
326 PANCREATITIS ACUTE 32
327 PERSONALITY CHANGE 32
328 PRODUCT DOSE OMISSION IN ERROR 32
329 PRODUCT SUBSTITUTION ISSUE 32
330 ASPIRATION 31
331 BLOOD SODIUM DECREASED 31
332 CARDIO-RESPIRATORY ARREST 31
333 ECHOLALIA 31
334 GASTROOESOPHAGEAL REFLUX DISEASE 31
335 HAEMATEMESIS 31
336 SUICIDE ATTEMPT 31
337 WOUND 31
338 AKATHISIA 30
339 CHOKING 30
340 DEVICE OCCLUSION 30
341 HEPATIC FUNCTION ABNORMAL 30
342 HYPERKALAEMIA 30
343 HYPOXIA 30
344 MOTOR DYSFUNCTION 30
345 MULTIPLE SCLEROSIS RELAPSE 30
346 ANGINA PECTORIS 29
347 DRUG LEVEL INCREASED 29
348 DRY EYE 29
349 DYSPNOEA EXERTIONAL 29
350 HAEMATOMA 29
351 HAEMORRHOIDS 29
352 HEAD DISCOMFORT 29
353 LACTIC ACIDOSIS 29
354 LEUKOCYTOSIS 29
355 ON AND OFF PHENOMENON 29
356 PRODUCT ADMINISTRATION INTERRUPTED 29
357 PRODUCT PRESCRIBING ERROR 29
358 RENAL DISORDER 29
359 RESPIRATORY DISTRESS 29
360 STRESS 29
361 BEDRIDDEN 28
362 COLITIS 28
363 EATING DISORDER 28
364 FAECES DISCOLOURED 28
365 FAILURE TO THRIVE 28
366 FEMORAL NECK FRACTURE 28
367 HYPOTONIA 28
368 MALNUTRITION 28
369 PETIT MAL EPILEPSY 28
370 POSTURE ABNORMAL 28
371 RASH PRURITIC 28
372 ANGIOEDEMA 27
373 BRAIN OEDEMA 27
374 FREEZING PHENOMENON 27
375 HEPATIC ENZYME INCREASED 27
376 HYPERGLYCAEMIA 27
377 INCOHERENT 27
378 LIVER DISORDER 27
379 MUSCLE TWITCHING 27
380 PULMONARY OEDEMA 27
381 RIB FRACTURE 27
382 SIALOADENITIS 27
383 ARTHRITIS 26
384 BLISTER 26
385 BRAIN INJURY 26
386 CIRCULATORY COLLAPSE 26
387 COORDINATION ABNORMAL 26
388 DYSGEUSIA 26
389 EYE SWELLING 26
390 HYPOACUSIS 26
391 MOOD ALTERED 26
392 MULTIPLE SCLEROSIS 26
393 NEUROTOXICITY 26
394 UPPER RESPIRATORY TRACT INFECTION 26
395 ACCIDENTAL EXPOSURE TO PRODUCT 25
396 ATRIOVENTRICULAR BLOCK COMPLETE 25
397 ATRIOVENTRICULAR BLOCK SECOND DEGREE 25
398 BLOOD PRESSURE ABNORMAL 25
399 CHROMATURIA 25
400 DRUG WITHDRAWAL SYNDROME 25
401 DYSPHONIA 25
402 RENAL FAILURE ACUTE 25
403 RESPIRATORY DISORDER 25
404 SCHIZOPHRENIA 25
405 THERAPY PARTIAL RESPONDER 25
406 THINKING ABNORMAL 25
407 THROAT IRRITATION 25
408 VITAMIN D DEFICIENCY 25
409 ANAPHYLACTIC REACTION 24
410 DISCOMFORT 24
411 DISEASE RECURRENCE 24
412 DISSEMINATED INTRAVASCULAR COAGULATION 24
413 EMOTIONAL DISTRESS 24
414 EYE PRURITUS 24
415 INFLUENZA LIKE ILLNESS 24
416 INJURY 24
417 IRON DEFICIENCY ANAEMIA 24
418 JOINT INJURY 24
419 LEUKOPENIA 24
420 LOWER RESPIRATORY TRACT INFECTION 24
421 METABOLIC ACIDOSIS 24
422 PRODUCT ADMINISTRATION ERROR 24
423 PRODUCT AVAILABILITY ISSUE 24
424 PRODUCT QUALITY ISSUE 24
425 SKIN LACERATION 24
426 WHEEZING 24
427 ANAL INCONTINENCE 23
428 APATHY 23
429 BLOOD ALKALINE PHOSPHATASE INCREASED 23
430 BLOOD UREA INCREASED 23
431 CHOREA 23
432 HAEMATOCHEZIA 23
433 MELAENA 23
434 METASTATIC NEOPLASM 23
435 NEOPLASM MALIGNANT 23
436 PEMPHIGOID 23
437 RESPIRATORY ARREST 23
438 SKIN DISCOLOURATION 23
439 STOMA SITE DISCHARGE 23
440 C-REACTIVE PROTEIN INCREASED 22
441 CEREBRAL ATROPHY 22
442 CYSTITIS 22
443 HAEMORRHAGIC STROKE 22
444 IMMOBILE 22
445 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 22
446 OROPHARYNGEAL PAIN 22
447 RESPIRATORY TRACT INFECTION 22
448 SUBARACHNOID HAEMORRHAGE 22
449 ANXIETY DISORDER 21
450 BRAIN FOG 21
451 COVID-19 PNEUMONIA 21
452 DECREASED ACTIVITY 21
453 DEVICE MALFUNCTION 21
454 FLATULENCE 21
455 FLUID INTAKE REDUCED 21
456 NASAL CONGESTION 21
457 SCREAMING 21
458 SEDATION COMPLICATION 21
459 STAPHYLOCOCCAL INFECTION 21
460 SURGERY 21
461 THERAPEUTIC RESPONSE SHORTENED 21
462 TORSADE DE POINTES 21
463 BLOOD CHOLESTEROL INCREASED 20
464 DRUG ERUPTION 20
465 EMOTIONAL DISORDER 20
466 FLUID RETENTION 20
467 HAEMATOCRIT DECREASED 20
468 INTENTIONAL OVERDOSE 20
469 MULTIPLE ORGAN DYSFUNCTION SYNDROME 20
470 PANCREATITIS 20
471 RASH ERYTHEMATOUS 20
472 RED BLOOD CELL COUNT DECREASED 20
473 THERAPEUTIC RESPONSE DECREASED 20
474 AGEUSIA 19
475 AKINESIA 19
476 BLOOD PRESSURE SYSTOLIC INCREASED 19
477 EOSINOPHILIC PLEURAL EFFUSION 19
478 GAMMA-GLUTAMYLTRANSFERASE INCREASED 19
479 HICCUPS 19
480 MIDDLE INSOMNIA 19
481 MUSCULOSKELETAL PAIN 19
482 MYOCARDIAL OEDEMA 19
483 SKIN ULCER 19
484 TOXIC ENCEPHALOPATHY 19
485 VENTRICULAR EXTRASYSTOLES 19
486 BODY TEMPERATURE INCREASED 18
487 BRADYARRHYTHMIA 18
488 CHOLELITHIASIS 18
489 CHOLESTASIS 18
490 DIPLOPIA 18
491 ELECTROCARDIOGRAM PR PROLONGATION 18
492 FEELING COLD 18
493 FEELING HOT 18
494 GASTRIC HAEMORRHAGE 18
495 HEPATOTOXICITY 18
496 ILLUSION 18
497 INSURANCE ISSUE 18
498 ISCHAEMIC STROKE 18
499 LACRIMATION INCREASED 18
500 LIVER INJURY 18
501 MUSCLE SPASTICITY 18
502 AGRANULOCYTOSIS 17
503 BURNING SENSATION 17
504 COMMUNICATION DISORDER 17
505 DEAFNESS 17
506 FAECALOMA 17
507 FRACTURE 17
508 FUNGAL INFECTION 17
509 INFLAMMATION 17
510 INTESTINAL OBSTRUCTION 17
511 KIDNEY INFECTION 17
512 NEURALGIA 17
513 PANIC ATTACK 17
514 SLUGGISHNESS 17
515 TERMINAL STATE 17
516 WRONG TECHNIQUE IN DRUG USAGE PROCESS 17
517 ACUTE RESPIRATORY FAILURE 16
518 APPLICATION SITE PRURITUS 16
519 BLOOD GLUCOSE DECREASED 16
520 BLOOD URINE PRESENT 16
521 BONE PAIN 16
522 BUNDLE BRANCH BLOCK RIGHT 16
523 DERMATITIS ALLERGIC 16
524 DRUG EFFECT LESS THAN EXPECTED 16
525 EYE MOVEMENT DISORDER 16
526 GLAUCOMA 16
527 HYPORESPONSIVE TO STIMULI 16
528 ILEUS PARALYTIC 16
529 INJECTION SITE BRUISING 16
530 METASTASES TO BONE 16
531 METASTASES TO LIVER 16
532 MICTURITION URGENCY 16
533 MOOD SWINGS 16
534 NEUROPSYCHOLOGICAL SYMPTOMS 16
535 PHOTOPHOBIA 16
536 PSYCHIATRIC SYMPTOM 16
537 REHABILITATION THERAPY 16
538 SCAR 16
539 TINNITUS 16
540 TROPONIN INCREASED 16
541 VIRAL INFECTION 16
542 ACUTE MYOCARDIAL INFARCTION 15
543 ATELECTASIS 15
544 BODY HEIGHT DECREASED 15
545 DERMATITIS 15
546 EXTRA DOSE ADMINISTERED 15
547 GASTRIC DISORDER 15
548 GLOMERULAR FILTRATION RATE DECREASED 15
549 HAEMORRHAGE INTRACRANIAL 15
550 HYPERREFLEXIA 15
551 INCORRECT PRODUCT ADMINISTRATION DURATION 15
552 INTESTINAL PSEUDO-OBSTRUCTION 15
553 LIMB INJURY 15
554 MUSCULOSKELETAL DISORDER 15
555 NOCTURIA 15
556 OSTEOPOROSIS 15
557 PERSECUTORY DELUSION 15
558 PNEUMONIA BACTERIAL 15
559 POLYDIPSIA 15
560 PRESCRIBED OVERDOSE 15
561 PULMONARY THROMBOSIS 15
562 REBOUND EFFECT 15
563 REFUSAL OF TREATMENT BY PATIENT 15
564 RESPIRATORY RATE INCREASED 15
565 ROAD TRAFFIC ACCIDENT 15
566 SQUAMOUS CELL CARCINOMA 15
567 STARING 15
568 STOMA SITE ERYTHEMA 15
569 STOMATITIS 15
570 SUSPECTED SUICIDE 15
571 THERAPY CHANGE 15
572 UPPER LIMB FRACTURE 15
573 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 14
574 BACTERAEMIA 14
575 CYANOSIS 14
576 DEMENTIA ALZHEIMER'S TYPE 14
577 DEVICE DIFFICULT TO USE 14
578 DIABETIC KETOACIDOSIS 14
579 DIVERTICULITIS 14
580 DRUG DEPENDENCE 14
581 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 14
582 EYE DISORDER 14
583 FOAMING AT MOUTH 14
584 HEPATITIS 14
585 HEPATOCELLULAR INJURY 14
586 INFUSION SITE ERYTHEMA 14
587 LOCALISED INFECTION 14
588 LUNG DISORDER 14
589 NERVOUS SYSTEM DISORDER 14
590 ORAL CANDIDIASIS 14
591 PARTIAL SEIZURES 14
592 PSORIASIS 14
593 RASH MACULAR 14
594 SARS-COV-2 TEST POSITIVE 14
595 SKIN ABRASION 14
596 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 14
597 SPUTUM DISCOLOURED 14
598 STOMA SITE HAEMORRHAGE 14
599 WHEELCHAIR USER 14
600 ANAEMIA MACROCYTIC 13
601 APHTHOUS ULCER 13
602 ATRIAL FLUTTER 13
603 BODY TEMPERATURE DECREASED 13
604 CONDUCTION DISORDER 13
605 DEVICE ALARM ISSUE 13
606 DRUG ADMINISTRATION ERROR 13
607 DRUG EFFECT INCOMPLETE 13
608 EXPIRED PRODUCT ADMINISTERED 13
609 FEAR 13
610 FREQUENT BOWEL MOVEMENTS 13
611 GASTRITIS 13
612 HYPERCALCAEMIA 13
613 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 13
614 HYPERPHAGIA 13
615 IMPAIRED HEALING 13
616 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 13
617 INJECTION SITE ERYTHEMA 13
618 LABORATORY TEST ABNORMAL 13
619 METABOLIC ENCEPHALOPATHY 13
620 MIOSIS 13
621 MOANING 13
622 NIGHT SWEATS 13
623 PLASMA CELL MYELOMA 13
624 POLYURIA 13
625 PRODUCT ADHESION ISSUE 13
626 PRODUCT DISTRIBUTION ISSUE 13
627 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 13
628 RESPIRATORY DEPRESSION 13
629 SCRATCH 13
630 SKIN CANCER 13
631 SPINAL OPERATION 13
632 SYSTEMIC LUPUS ERYTHEMATOSUS 13
633 THROAT TIGHTNESS 13
634 VENTRICULAR FIBRILLATION 13
635 VISUAL ACUITY REDUCED 13
636 ABDOMINAL PAIN LOWER 12
637 AORTIC ANEURYSM 12
638 APPLICATION SITE ERYTHEMA 12
639 ASCITES 12
640 BACK DISORDER 12
641 BASAL CELL CARCINOMA 12
642 BRADYPHRENIA 12
643 BREAST CANCER 12
644 BRUXISM 12
645 CARDIAC FAILURE ACUTE 12
646 CLOSTRIDIUM DIFFICILE INFECTION 12
647 DEVICE LEAKAGE 12
648 DIZZINESS POSTURAL 12
649 ECZEMA 12
650 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 12
651 END STAGE RENAL DISEASE 12
652 EOSINOPHILIA 12
653 FEELING JITTERY 12
654 FRONTOTEMPORAL DEMENTIA 12
655 GASTRIC ULCER 12
656 GASTROINTESTINAL INFECTION 12
657 HEART RATE IRREGULAR 12
658 HEPATIC FAILURE 12
659 HEPATOMEGALY 12
660 HYPOCALCAEMIA 12
661 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 12
662 ILEUS 12
663 INFUSION SITE PAIN 12
664 INITIAL INSOMNIA 12
665 LIP SWELLING 12
666 LOGORRHOEA 12
667 MATERNAL EXPOSURE DURING PREGNANCY 12
668 MITRAL VALVE INCOMPETENCE 12
669 MOUTH ULCERATION 12
670 NEUTROPHIL COUNT DECREASED 12
671 OLIGURIA 12
672 ORAL PAIN 12
673 PNEUMONITIS 12
674 POST-TRAUMATIC HEADACHE 12
675 PRODUCT PRESCRIBING ISSUE 12
676 RETCHING 12
677 SNEEZING 12
678 SOCIAL AVOIDANT BEHAVIOUR 12
679 SPINAL FRACTURE 12
680 STUPOR 12
681 SWOLLEN TONGUE 12
682 TASTE DISORDER 12
683 TRANSAMINASES INCREASED 12
684 TYPE 2 DIABETES MELLITUS 12
685 WRONG PRODUCT ADMINISTERED 12
686 AFFECTIVE DISORDER 11
687 BLOOD POTASSIUM INCREASED 11
688 CARDIOMEGALY 11
689 CENTRAL PAIN SYNDROME 11
690 CRANIOCEREBRAL INJURY 11
691 DRUG PRESCRIBING ERROR 11
692 FEBRILE NEUTROPENIA 11
693 FRUSTRATION TOLERANCE DECREASED 11
694 FULL BLOOD COUNT ABNORMAL 11
695 GOUT 11
696 HAEMOPTYSIS 11
697 IMPAIRED GASTRIC EMPTYING 11
698 IMPULSIVE BEHAVIOUR 11
699 INFUSION SITE SWELLING 11
700 LIMB DISCOMFORT 11
701 LIVER FUNCTION TEST INCREASED 11
702 LOWER GASTROINTESTINAL HAEMORRHAGE 11
703 LUNG CONSOLIDATION 11
704 LYMPHADENOPATHY 11
705 LYMPHOCYTE COUNT DECREASED 11
706 MACULAR DEGENERATION 11
707 NEOPLASM PROGRESSION 11
708 NOSOCOMIAL INFECTION 11
709 PERIPHERAL COLDNESS 11
710 PETECHIAE 11
711 PRODUCT DISPENSING ERROR 11
712 PRODUCT INEFFECTIVE 11
713 PRODUCT PHYSICAL ISSUE 11
714 PRODUCT STORAGE ERROR 11
715 PROSTATE CANCER 11
716 PSYCHOTIC SYMPTOM 11
717 PULMONARY FIBROSIS 11
718 RESTLESS LEGS SYNDROME 11
719 SEIZURE LIKE PHENOMENA 11
720 SENSORY DISTURBANCE 11
721 SLEEP TALKING 11
722 SLOW SPEECH 11
723 STATUS EPILEPTICUS 11
724 SUDDEN DEATH 11
725 ULCER 11
726 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 11
727 ACTIVITIES OF DAILY LIVING IMPAIRED 10
728 ARTERIOSCLEROSIS 10
729 BLOOD BILIRUBIN INCREASED 10
730 BLOOD TEST ABNORMAL 10
731 BLOOD TRIGLYCERIDES INCREASED 10
732 BRAIN NEOPLASM 10
733 CEREBRAL DISORDER 10
734 CLONUS 10
735 COLD SWEAT 10
736 COLITIS MICROSCOPIC 10
737 COMPLICATION ASSOCIATED WITH DEVICE 10
738 EMOTIONAL POVERTY 10
739 HAEMODYNAMIC INSTABILITY 10
740 HERNIA 10
741 HIP SURGERY 10
742 INTENTIONAL SELF-INJURY 10
743 INTERNAL HAEMORRHAGE 10
744 MALIGNANT MELANOMA 10
745 MARASMUS 10
746 METASTASES TO LUNG 10
747 METASTASES TO MENINGES 10
748 NEUTROPHIL COUNT INCREASED 10
749 PARALYSIS 10
750 PNEUMOTHORAX 10
751 PROSTATIC SPECIFIC ANTIGEN INCREASED 10
752 PROSTATOMEGALY 10
753 PROTEIN TOTAL DECREASED 10
754 PROTEINURIA 10
755 PULMONARY CONGESTION 10
756 PULMONARY MASS 10
757 SEASONAL ALLERGY 10
758 SKIN HAEMORRHAGE 10
759 SKIN LESION 10
760 SLEEP APNOEA SYNDROME 10
761 UROSEPSIS 10
762 WALKING AID USER 10
763 ACIDOSIS 9
764 ACNE 9
765 ANGLE CLOSURE GLAUCOMA 9
766 ASPHYXIA 9
767 BACK INJURY 9
768 BIFASCICULAR BLOCK 9
769 BONE MARROW FAILURE 9
770 CARDIAC FAILURE CHRONIC 9
771 CENTRAL NERVOUS SYSTEM LESION 9
772 COMA SCALE ABNORMAL 9
773 COMPRESSION FRACTURE 9
774 CRYPTOCOCCOSIS 9
775 CYTOLYTIC HEPATITIS 9
776 DEVICE KINK 9
777 DISORGANISED SPEECH 9
778 DRUG RESISTANCE 9
779 ENCEPHALITIS 9
780 FOETAL EXPOSURE DURING PREGNANCY 9
781 FOOT DEFORMITY 9
782 FORMICATION 9
783 FULL BLOOD COUNT DECREASED 9
784 GAZE PALSY 9
785 GLYCOSYLATED HAEMOGLOBIN INCREASED 9
786 HEMIPLEGIA 9
787 HEPATIC CIRRHOSIS 9
788 HIATUS HERNIA 9
789 HYDROCEPHALUS 9
790 HYDRONEPHROSIS 9
791 HYPERPYREXIA 9
792 HYPERURICAEMIA 9
793 HYPOALBUMINAEMIA 9
794 INADEQUATE ANALGESIA 9
795 INJECTION SITE HAEMORRHAGE 9
796 INJECTION SITE PRURITUS 9
797 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 9
798 JOINT STIFFNESS 9
799 KNEE ARTHROPLASTY 9
800 LACK OF SPONTANEOUS SPEECH 9
801 LANGUAGE DISORDER 9
802 LEFT VENTRICULAR DYSFUNCTION 9
803 LUNG INFECTION 9
804 MASS 9
805 MIXED DEMENTIA 9
806 MUSCULOSKELETAL CHEST PAIN 9
807 NYSTAGMUS 9
808 OESOPHAGEAL DILATATION 9
809 ONYCHOMYCOSIS 9
810 PERFORMANCE STATUS DECREASED 9
811 PERIORBITAL SWELLING 9
812 POSTOPERATIVE WOUND INFECTION 9
813 RASH PAPULAR 9
814 RENAL INJURY 9
815 SHOCK HAEMORRHAGIC 9
816 SINUS TACHYCARDIA 9
817 SOMNAMBULISM 9
818 SPUR CELL ANAEMIA 9
819 STEREOTYPY 9
820 STEVENS-JOHNSON SYNDROME 9
821 SUPERFICIAL SIDEROSIS OF CENTRAL NERVOUS SYSTEM 9
822 TACHYPNOEA 9
823 THERAPEUTIC DRUG MONITORING ANALYSIS NOT PERFORMED 9
824 THYROID DISORDER 9
825 VOLVULUS 9
826 AFFECT LABILITY 8
827 ANHEDONIA 8
828 APPETITE DISORDER 8
829 APPLICATION SITE HYPERSENSITIVITY 8
830 APPLICATION SITE RASH 8
831 APTYALISM 8
832 ARTHROPATHY 8
833 BLINDNESS UNILATERAL 8
834 BLOOD ALBUMIN DECREASED 8
835 BLOOD CHLORIDE INCREASED 8
836 BLOOD IRON DECREASED 8
837 CARDIAC PACEMAKER INSERTION 8
838 CARDIOVASCULAR DISORDER 8
839 DERMATITIS CONTACT 8
840 DEVICE USE ISSUE 8
841 DIET REFUSAL 8
842 DISEASE COMPLICATION 8
843 DRUG DOSE OMISSION BY DEVICE 8
844 DRUG EFFECT DECREASED 8
845 EAR INFECTION 8
846 ECCHYMOSIS 8
847 ERUCTATION 8
848 ESCHERICHIA URINARY TRACT INFECTION 8
849 EXFOLIATIVE RASH 8
850 EXTRASYSTOLES 8
851 FACE OEDEMA 8
852 FACIAL PARALYSIS 8
853 FACIAL SPASM 8
854 HAEMOLYSIS 8
855 HEPATIC STEATOSIS 8
856 HYPERCHOLESTEROLAEMIA 8
857 INCORRECT DOSE ADMINISTERED BY DEVICE 8
858 INFUSION SITE EXTRAVASATION 8
859 LACUNAR INFARCTION 8
860 LOWER LIMB FRACTURE 8
861 LUNG CANCER METASTATIC 8
862 LUNG INFILTRATION 8
863 MAJOR DEPRESSION 8
864 MONOCYTE COUNT INCREASED 8
865 MUSCLE CONTRACTURE 8
866 MUSCLE TIGHTNESS 8
867 MUTISM 8
868 OSTEOARTHRITIS 8
869 PARKINSONIAN GAIT 8
870 PERICARDIAL EFFUSION 8
871 PERIORBITAL OEDEMA 8
872 PHLEBITIS 8
873 POST PROCEDURAL COMPLICATION 8
874 POVERTY OF SPEECH 8
875 PREMATURE DELIVERY 8
876 PRODUCT PREPARATION ERROR 8
877 QUALITY OF LIFE DECREASED 8
878 RASH MACULO-PAPULAR 8
879 REPETITIVE SPEECH 8
880 RESPIRATORY TRACT CONGESTION 8
881 SHOCK 8
882 SKIN IRRITATION 8
883 SPINAL PAIN 8
884 TOOTH LOSS 8
885 TORTICOLLIS 8
886 TRIFASCICULAR BLOCK 8
887 UPPER GASTROINTESTINAL HAEMORRHAGE 8
888 VASCULAR DEMENTIA 8
889 VENOUS THROMBOSIS 8
890 VENTRICULAR TACHYCARDIA 8
891 WOUND HAEMORRHAGE 8
892 WRIST FRACTURE 8
893 ACCIDENTAL POISONING 7
894 ANOSMIA 7
895 AUTONOMIC NERVOUS SYSTEM IMBALANCE 7
896 BENIGN PROSTATIC HYPERPLASIA 7
897 BIPOLAR DISORDER 7
898 BLADDER CANCER 7
899 BLADDER DISORDER 7
900 BLOOD LACTATE DEHYDROGENASE INCREASED 7
901 BRADYPNOEA 7
902 CANDIDA INFECTION 7
903 CARDIAC MURMUR 7
904 CARDIOGENIC SHOCK 7
905 CARDIOMYOPATHY 7
906 CEREBRAL ISCHAEMIA 7
907 CERVICAL SPINAL STENOSIS 7
908 CHOLECYSTITIS 7
909 CLAVICLE FRACTURE 7
910 COGWHEEL RIGIDITY 7
911 CONCOMITANT DISEASE AGGRAVATED 7
912 CORONARY ARTERY OCCLUSION 7
913 CUSHINGOID 7
914 DEPRESSIVE SYMPTOM 7
915 DEVICE BREAKAGE 7
916 DEVICE PHYSICAL PROPERTY ISSUE 7
917 DIABETES MELLITUS INADEQUATE CONTROL 7
918 DROPPED HEAD SYNDROME 7
919 DYSGRAPHIA 7
920 DYSLIPIDAEMIA 7
921 ELECTROLYTE IMBALANCE 7
922 ESSENTIAL HYPERTENSION 7
923 EXCESSIVE CERUMEN PRODUCTION 7
924 EYE DISCHARGE 7
925 FIBROMYALGIA 7
926 FOOT FRACTURE 7
927 GASTROINTESTINAL HYPOMOTILITY 7
928 HAEMARTHROSIS 7
929 HAEMATOCRIT INCREASED 7
930 HEPATIC ENCEPHALOPATHY 7
931 HIP ARTHROPLASTY 7
932 IMPAIRED DRIVING ABILITY 7
933 IMPAIRED SELF-CARE 7
934 INCREASED APPETITE 7
935 INFARCTION 7
936 INJECTION SITE INDURATION 7
937 INJECTION SITE SWELLING 7
938 INTERVERTEBRAL DISC DEGENERATION 7
939 INTERVERTEBRAL DISC PROTRUSION 7
940 JOINT DISLOCATION 7
941 LIGAMENT SPRAIN 7
942 LOW DENSITY LIPOPROTEIN DECREASED 7
943 LUMBAR SPINAL STENOSIS 7
944 METASTASIS 7
945 MOUTH SWELLING 7
946 MUCOSAL INFLAMMATION 7
947 MULTIPLE FRACTURES 7
948 MYASTHENIA GRAVIS 7
949 MYELODYSPLASTIC SYNDROME 7
950 MYELOSUPPRESSION 7
951 NEPHROGENIC ANAEMIA 7
952 NEUROPSYCHIATRIC SYMPTOMS 7
953 OBSESSIVE-COMPULSIVE DISORDER 7
954 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7
955 PATIENT ELOPEMENT 7
956 PELVIC FRACTURE 7
957 PNEUMONIA KLEBSIELLA 7
958 POLYP 7
959 PROCEDURAL PAIN 7
960 PRODUCT SIZE ISSUE 7
961 PYELONEPHRITIS 7
962 RASH GENERALISED 7
963 RED BLOOD CELL COUNT INCREASED 7
964 RHEUMATOID ARTHRITIS 7
965 RHYTHM IDIOVENTRICULAR 7
966 RIGHT VENTRICULAR FAILURE 7
967 SECRETION DISCHARGE 7
968 SEXUALLY INAPPROPRIATE BEHAVIOUR 7
969 SINUS DISORDER 7
970 SKIN ATROPHY 7
971 SKIN INJURY 7
972 SKIN OEDEMA 7
973 SLEEP TERROR 7
974 SPINAL STENOSIS 7
975 SPONDYLITIS 7
976 STAPHYLOCOCCAL SEPSIS 7
977 STOMA SITE HYPERGRANULATION 7
978 STOMA SITE INFECTION 7
979 TEMPERATURE INTOLERANCE 7
980 TENSION 7
981 THERAPEUTIC PRODUCT EFFECT VARIABLE 7
982 THOUGHT BLOCKING 7
983 TRANSFUSION 7
984 WRONG PATIENT RECEIVED MEDICATION 7
985 ABSCESS 6
986 ABULIA 6
987 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 6
988 ANAEMIA NEONATAL 6
989 ANEURYSM 6
990 ANKLE FRACTURE 6
991 AORTIC VALVE INCOMPETENCE 6
992 APALLIC SYNDROME 6
993 APNOEA 6
994 APPLICATION SITE IRRITATION 6
995 APRAXIA 6
996 ARRHYTHMIA SUPRAVENTRICULAR 6
997 BACTERIAL INFECTION 6
998 BILIARY SEPSIS 6
999 BOWEL MOVEMENT IRREGULARITY 6